JP2017534591A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017534591A5 JP2017534591A5 JP2017516735A JP2017516735A JP2017534591A5 JP 2017534591 A5 JP2017534591 A5 JP 2017534591A5 JP 2017516735 A JP2017516735 A JP 2017516735A JP 2017516735 A JP2017516735 A JP 2017516735A JP 2017534591 A5 JP2017534591 A5 JP 2017534591A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound according
- aryl
- heteroaryl
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462056946P | 2014-09-29 | 2014-09-29 | |
| US62/056,946 | 2014-09-29 | ||
| PCT/US2015/052611 WO2016053855A1 (en) | 2014-09-29 | 2015-09-28 | Sphingosine-1-phospate receptor modulators for treatment of cardiopulmonary disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017534591A JP2017534591A (ja) | 2017-11-24 |
| JP2017534591A5 true JP2017534591A5 (enExample) | 2018-10-25 |
| JP6770511B2 JP6770511B2 (ja) | 2020-10-14 |
Family
ID=55631308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017516735A Expired - Fee Related JP6770511B2 (ja) | 2014-09-29 | 2015-09-28 | 心肺障害の処置のためのスフィンゴシン−１−リン酸受容体モジュレーター |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10323029B2 (enExample) |
| EP (1) | EP3209732B1 (enExample) |
| JP (1) | JP6770511B2 (enExample) |
| KR (1) | KR102307037B1 (enExample) |
| CN (1) | CN107001806B (enExample) |
| AU (1) | AU2015324163B2 (enExample) |
| CA (1) | CA2962922C (enExample) |
| EA (1) | EA031503B1 (enExample) |
| ES (1) | ES2895174T3 (enExample) |
| IL (1) | IL251387B (enExample) |
| SG (1) | SG11201702483QA (enExample) |
| WO (1) | WO2016053855A1 (enExample) |
| ZA (1) | ZA201702403B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015324163B2 (en) | 2014-09-29 | 2020-06-25 | The Scripps Research Institute | Sphingosine-1-phospate receptor modulators for treatment of cardiopulmonary disorders |
| WO2017144183A1 (en) * | 2016-02-24 | 2017-08-31 | Acesion Pharma Aps | Novel potassium channel inhibitors |
| US11049009B2 (en) * | 2017-06-12 | 2021-06-29 | Western Digital Technologies, Inc. | Identifying memory block write endurance using machine learning |
| US20200316021A1 (en) * | 2017-09-29 | 2020-10-08 | Novartis Ag | Dosing Regimen of Siponimod |
| CN112469697B (zh) * | 2018-07-11 | 2025-02-14 | 鲁贝多生命科学公司 | 抗衰老组合物及其用途 |
| KR102218280B1 (ko) * | 2019-01-30 | 2021-02-22 | 주식회사 엑세쏘바이오파마 | P1p 유도체의 패혈증 치료제 용도 |
| AU2020267356B2 (en) * | 2019-05-03 | 2025-04-24 | Praxis Precision Medicines, Inc. | KCNT1 inhibitors and methods of use |
| CN113200971B (zh) * | 2021-05-14 | 2022-06-28 | 济南大学 | 一类具有芳香基哌嗪结构的吲哚恶二唑衍生物的合成和应用 |
| EP4342882A4 (en) * | 2021-05-17 | 2024-08-28 | HK inno.N Corporation | BENZAMIDE DERIVATIVE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER CONTAINING IT AS ACTIVE INGREDIENT |
| WO2025176104A1 (en) | 2024-02-19 | 2025-08-28 | Ono Pharmaceutical Co., Ltd. | Heterocyclic derivatives having s1p3 receptor antagonistic activity |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2085736A (en) * | 1933-12-06 | 1937-07-06 | Du Pont | Compounds of the triphenylmethane series |
| US3217012A (en) * | 1960-10-26 | 1965-11-09 | Purdue Research Foundation | Substituted pyridines, process for and new compositions |
| US3916000A (en) * | 1971-07-21 | 1975-10-28 | Commw Scient Ind Res Org | Alkylation process |
| EP0355864A3 (en) * | 1984-03-15 | 1991-09-18 | Wako Pure Chemical Industries, Ltd. | Method of quantitatively measuring an oxidative substance by using triphenyl methane type leuco compounds as coloring matter |
| US6028103A (en) * | 1994-09-16 | 2000-02-22 | Children's Medical Center Corporation | Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation |
| US20020156301A1 (en) * | 1997-06-17 | 2002-10-24 | Sumitomo Chemical Co., Ltd. | Triphenylmethane derivatives and use thereof |
| JP4709488B2 (ja) * | 2002-01-18 | 2011-06-22 | メルク・シャープ・エンド・ドーム・コーポレイション | Ｅｄｇ受容体作動薬としてのＮ−（ベンジル）アミノアルキルカルボン酸化合物、ホスフィン酸化合物、ホスホン酸化合物およびテトラゾール類 |
| US20060287537A1 (en) * | 2003-08-27 | 2006-12-21 | Stanislav Radl | Method of removing the triphenylmethane protecting group |
| CN101528699A (zh) * | 2005-11-23 | 2009-09-09 | 布里斯托尔—迈尔斯斯奎布公司 | 杂环胆固醇酯转运蛋白抑制剂 |
| US7888376B2 (en) * | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| CA2659952A1 (en) * | 2006-08-23 | 2008-02-28 | Wyeth | 8-hydroxyquinoline compounds and methods thereof |
| US8445686B2 (en) | 2007-08-27 | 2013-05-21 | Abbvie Inc. | 4-(4-pyridinyl)-benzamides and their use as rock activity modulators |
| WO2009117269A1 (en) * | 2008-03-18 | 2009-09-24 | Merck & Co., Inc. | Substituted 4-hydroxypyrimidine-5-carboxamides |
| EP2297117B1 (en) * | 2008-05-19 | 2012-10-31 | Merck Sharp & Dohme Corp. | Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| WO2010014948A1 (en) * | 2008-08-01 | 2010-02-04 | The University Of Utah Research Foundation | Methods of treatment using wnt inhibitors |
| WO2010056758A1 (en) * | 2008-11-12 | 2010-05-20 | Yangbo Feng | Quinazoline derivatives as kinase inhibitors |
| JP2013028538A (ja) * | 2009-11-13 | 2013-02-07 | Dainippon Sumitomo Pharma Co Ltd | 新規アミド誘導体 |
| CN103338764A (zh) * | 2010-12-03 | 2013-10-02 | 阿勒根公司 | 作为鞘氨醇1-磷酸(s1p)受体调节剂的新型氮杂环丁烷衍生物 |
| AU2011337004A1 (en) | 2010-12-03 | 2013-07-11 | Allergan, Inc. | Novel phenyl oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| KR20130133234A (ko) | 2010-12-03 | 2013-12-06 | 알러간, 인코포레이티드 | 스핑고신 1-포스페이트 (s1p) 수용체 조절제로서의 신규한 피리딘 유도체 |
| CA2839699A1 (en) * | 2011-06-24 | 2012-12-27 | Amgen Inc. | Trpm8 antagonists and their use in treatments |
| DE202013011832U1 (de) * | 2012-04-11 | 2014-07-25 | Fluoron Gmbh | Färbemittel |
| US9410058B2 (en) | 2014-04-10 | 2016-08-09 | United States Gypsum Company | Compositions and methods for water-resistant gypsum fiber products |
| AU2015324163B2 (en) | 2014-09-29 | 2020-06-25 | The Scripps Research Institute | Sphingosine-1-phospate receptor modulators for treatment of cardiopulmonary disorders |
-
2015
- 2015-09-28 AU AU2015324163A patent/AU2015324163B2/en not_active Ceased
- 2015-09-28 WO PCT/US2015/052611 patent/WO2016053855A1/en not_active Ceased
- 2015-09-28 JP JP2017516735A patent/JP6770511B2/ja not_active Expired - Fee Related
- 2015-09-28 ES ES15846300T patent/ES2895174T3/es active Active
- 2015-09-28 EP EP15846300.0A patent/EP3209732B1/en active Active
- 2015-09-28 SG SG11201702483QA patent/SG11201702483QA/en unknown
- 2015-09-28 KR KR1020177011768A patent/KR102307037B1/ko not_active Expired - Fee Related
- 2015-09-28 EA EA201790513A patent/EA031503B1/ru unknown
- 2015-09-28 US US15/514,891 patent/US10323029B2/en active Active
- 2015-09-28 CN CN201580059828.7A patent/CN107001806B/zh not_active Expired - Fee Related
- 2015-09-28 CA CA2962922A patent/CA2962922C/en active Active
-
2017
- 2017-03-26 IL IL251387A patent/IL251387B/en active IP Right Grant
- 2017-04-05 ZA ZA2017/02403A patent/ZA201702403B/en unknown
-
2019
- 2019-06-11 US US16/437,007 patent/US11034691B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017534591A5 (enExample) | ||
| TWI400234B (zh) | 作為組織胺ｈ4受體調節劑之苯并咪唑-２-基嘧啶類及吡類 | |
| JP2020531422A5 (enExample) | ||
| JP2013523802A5 (enExample) | ||
| JP2012507522A5 (enExample) | ||
| JP2016515096A5 (enExample) | ||
| JP2020510015A5 (enExample) | ||
| JP2015532287A5 (enExample) | ||
| JP2016516699A5 (enExample) | ||
| JP2018534348A5 (enExample) | ||
| JP2016530259A5 (enExample) | ||
| JP2019524883A5 (enExample) | ||
| JP2016500111A5 (enExample) | ||
| JP2016529306A5 (enExample) | ||
| JP2015526411A5 (enExample) | ||
| JP7644823B2 (ja) | ピリドン多環縮合環系誘導体及びその使用 | |
| JP2016511753A5 (enExample) | ||
| JP2017506666A5 (enExample) | ||
| JP2014097964A5 (enExample) | ||
| JP2018528182A (ja) | ６−（アリールまたはヘテロアリール）−１，３，５−トリアジン−２，４−ジオール及び６−（アリールまたはヘテロアリール）−１，３，５−トリアジン−２，４−ジアミンを調製する方法 | |
| JP2019505529A5 (enExample) | ||
| JP2015509075A5 (enExample) | ||
| JP2017537886A5 (enExample) | ||
| JP5749410B2 (ja) | ジヒドロピロロ［１，２−ｃ］イミダゾリルアルドステロンシンターゼまたはアロマターゼ阻害薬の新たな形態および塩 | |
| JP2016528273A5 (enExample) |